Summaries by Inventor Maher, Christopher

Novel Long Non-coding RNA for the Treatment of Colorectal Cancer
Cabanski, Christopher ; Fields, Ryan ; Maher, Christopher ; Ryan ; Silva-Fisher, Jessica
T-018788

Publication date: 4/28/2026 Value Proposition: Non-coding RNA as a novel biomarker and therapeutic target for treating colon cancer.  Technology Description    Researchers at Washington University in St. Louis have developed a novel non-coding RNA, nam…

Long non-coding RNA as cancer biomarker and drug target
Cabanski, Christopher ; Fields, Ryan ; Maher, Christopher ; Silva-Fisher, Jessica
T-018788

— Technology Description Researchers in Prof. Christopher Maher’s research program (in conjunction with collaborator Ryan Fields) discovered that RAMS11 (RNA Associated with Metastasis 11), a novel long non-coding RNA, (i) promotes metastatic disease, (ii) confers resistance to topoisomerase i…

Liquid biopsy assay for personalized prostate cancer treatment
Chaudhuri, Aadel ; Maher, Christopher ; Pachynski, Russell
T-019287

— Technology Description A team of researchers at Washington University has developed “EnhanceAR-Seq”, a circulating tumor DNA (ctDNA) assay that predicts which patients are at high risk for developing resistance to androgen receptor (AR)-directed treatment for metastatic prostate cancer…

New Set of Biomarkers as a Therapeutic Target Across Cancers
Ly, Amy ; Maher, Christopher ; Maher, Nicole ; Nickless, Andrew ; Webster, Jace ; Zhang, Jin
T-019924

— Published date: 1/13/2026 Value Proposition: Predictive biomarkers that can identify patients that would respond well to HER2 targeted breast cancer treatment that are not currently being treated this way. Technology Description Researchers at Washington University in St. Louis have establis…